Giulio Francesco Romiti | Ricerc@Sapienza

Publications

Title	Published on	Year
Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial	INTERNAL AND EMERGENCY MEDICINE	2024
Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry	JOURNAL OF CLINICAL MEDICINE	2024
Hypoalbuminemia as predictor of thrombotic events in patients with community-acquired pneumonia	INTERNATIONAL JOURNAL OF CARDIOLOGY	2024
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2024
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry	BMC MEDICINE	2024
Prediction of new-onset atrial fibrillation with the C2HEST score in patients admitted with community-acquired pneumonia	INFECTION	2024
Educational status and the risk of adverse outcomes in Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry	MINERVA MEDICA	2024
A Focus on the Pathophysiology of Adrenomedullin Expression: Endothelitis and Organ Damage in Severe Viral and Bacterial Infections	CELLS	2024
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry	INTERNAL AND EMERGENCY MEDICINE	2024
Impact of Frailty Dynamics in Patients With Atrial Fibrillation: Learning How Clinical Complexity Increases Risk in Cardiovascular Diseases	CIRCULATION. CARDIOVASCULAR QUALITY AND OUTCOMES	2024
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2024
Anticoagulation in patients with atrial fibrillation and chronic kidney disease: clinical complexity beyond thromboembolism	INTERNAL AND EMERGENCY MEDICINE	2024
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III	DIABETES, OBESITY AND METABOLISM	2024
The 2024 ESC Guidelines for diagnosis and management of AF: A clinicians’ perspective	THROMBOSIS AND HAEMOSTASIS	2024
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial	JOURNAL OF GENERAL INTERNAL MEDICINE	2024
In subclinical AF, the benefit of apixaban vs. aspirin on stroke or systemic embolism trended higher with CHA2DS2-VASc >4	ANNALS OF INTERNAL MEDICINE	2024
Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status	ECLINICALMEDICINE	2024
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries	BMC MEDICINE	2024
Inflammation, lipids and cardiovascular risk: The quest for improving risk stratification and prognosis in ischemic heart disease	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION	2024
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2024

ERC

LS4_10
LS7_12
LS7_14

KET

Big data & computing

Interessi di ricerca

Keywords

atrial fibrillation

anticoagulants

complexity

multimorbidity

frailty